Asthma: increased risk for severe pneumonia with inhaled corticosteroids

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • In patients with asthma, current ICS use was associated with significantly increased risk of being hospitalized for pneumonia, especially with doses ≥500 µg of fluticasone-equivalent per day. 
  • The risk associated with budesonide (Pulmicort) and fluticasone (Flixotide) were similar.
  • ...